Business Description
![Agenus Inc Agenus Inc logo](https://static.gurufocus.com/logos/0C00000ACP.png?14)
Agenus Inc
NAICS : 325414
SIC : 2836
ISIN : US00847G7051
Description
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.6 | |||||
Equity-to-Asset | -0.79 | |||||
Debt-to-Equity | -0.44 | |||||
Debt-to-EBITDA | -0.71 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -12.62 | |||||
Beneish M-Score | -2.02 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.1 | |||||
3-Year EBITDA Growth Rate | 15 | |||||
3-Year EPS without NRI Growth Rate | 12.4 | |||||
3-Year FCF Growth Rate | 7.5 | |||||
3-Year Book Growth Rate | 26.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 16.62 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.11 | |||||
9-Day RSI | 44.78 | |||||
14-Day RSI | 48.11 | |||||
6-1 Month Momentum % | -1.96 | |||||
12-1 Month Momentum % | -50.97 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.24 | |||||
Quick Ratio | 0.24 | |||||
Cash Ratio | 0.21 | |||||
Days Sales Outstanding | 13.61 | |||||
Days Payable | 82.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26.2 | |||||
Shareholder Yield % | -26.37 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -37.72 | |||||
Operating Margin % | -85.64 | |||||
Net Margin % | -148.31 | |||||
FCF Margin % | -131.35 | |||||
ROA % | -70.31 | |||||
ROIC % | -40.22 | |||||
ROC (Joel Greenblatt) % | -83.08 | |||||
ROCE % | -116.55 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.41 | |||||
EV-to-EBIT | -2.77 | |||||
EV-to-Forward-EBIT | -5.46 | |||||
EV-to-EBITDA | -3.09 | |||||
EV-to-Revenue | 2.39 | |||||
EV-to-Forward-Revenue | 2.07 | |||||
EV-to-FCF | -1.82 | |||||
Price-to-Median-PS-Value | 0.05 | |||||
Earnings Yield (Greenblatt) % | -36.1 | |||||
FCF Yield % | -70.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AGEN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Agenus Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 161.416 | ||
EPS (TTM) ($) | -70.4 | ||
Beta | 1.36 | ||
Volatility % | 53.54 | ||
14-Day RSI | 48.11 | ||
14-Day ATR ($) | 1.525446 | ||
20-Day SMA ($) | 15.6065 | ||
12-1 Month Momentum % | -50.97 | ||
52-Week Range ($) | 4.775 - 38.6 | ||
Shares Outstanding (Mil) | 21 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Agenus Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Agenus Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Agenus Inc Frequently Asked Questions
What is Agenus Inc(AGEN)'s stock price today?
The current price of AGEN is $14.28. The 52 week high of AGEN is $38.60 and 52 week low is $4.78.
When is next earnings date of Agenus Inc(AGEN)?
The next earnings date of Agenus Inc(AGEN) is 2024-08-08 Est..
Does Agenus Inc(AGEN) pay dividends? If so, how much?
Agenus Inc(AGEN) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |